NAE1
Basic information
Region (hg38): 16:66802875-66873256
Previous symbols: [ "APPBP1" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia (Limited), mode of inheritance: AR
- neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Allergy/Immunology/Infectious; Craniofacial; Musculoskeletal; Neurologic | 36608681 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAE1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 0 |
Variants in NAE1
This is a list of pathogenic ClinVar variants found in the NAE1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-66803065-T-G | not specified | Uncertain significance (Mar 12, 2024) | ||
16-66803085-G-C | not specified | Uncertain significance (Jun 11, 2021) | ||
16-66805818-T-C | Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia | Uncertain significance (Mar 29, 2024) | ||
16-66805825-A-T | not specified | Uncertain significance (Apr 26, 2023) | ||
16-66805996-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
16-66808562-C-T | Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia | Pathogenic (Jan 27, 2023) | ||
16-66809049-C-A | not specified | Uncertain significance (Sep 30, 2021) | ||
16-66810410-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
16-66810413-C-T | not specified | Uncertain significance (Jun 08, 2022) | ||
16-66810741-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
16-66813625-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
16-66813805-G-C | Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia | Pathogenic (-) | ||
16-66813810-G-A | not specified | Uncertain significance (Apr 07, 2022) | ||
16-66813818-T-G | not specified | Uncertain significance (Aug 02, 2021) | ||
16-66816612-T-C | not specified | Uncertain significance (Jul 27, 2022) | ||
16-66817004-A-C | not specified | Uncertain significance (Jun 16, 2023) | ||
16-66817477-T-C | not specified | Uncertain significance (Nov 10, 2022) | ||
16-66818537-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
16-66818538-A-G | not specified | Uncertain significance (Oct 20, 2021) | ||
16-66818589-T-C | not specified | Uncertain significance (May 20, 2024) | ||
16-66818619-T-C | not specified | Uncertain significance (May 24, 2023) | ||
16-66821477-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
16-66823234-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
16-66823268-G-C | not specified | Uncertain significance (Mar 22, 2023) | ||
16-66823284-T-C | not specified | Uncertain significance (May 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NAE1 | protein_coding | protein_coding | ENST00000290810 | 20 | 70382 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.80e-13 | 0.800 | 125697 | 0 | 51 | 125748 | 0.000203 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.09 | 218 | 268 | 0.813 | 0.0000130 | 3498 |
Missense in Polyphen | 35 | 76.376 | 0.45826 | 995 | ||
Synonymous | 1.04 | 79 | 91.6 | 0.862 | 0.00000456 | 946 |
Loss of Function | 1.85 | 26 | 38.3 | 0.678 | 0.00000216 | 454 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000348 | 0.000348 |
Ashkenazi Jewish | 0.00104 | 0.000993 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000471 | 0.0000462 |
European (Non-Finnish) | 0.000152 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000287 | 0.000261 |
Other | 0.00103 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Regulatory subunit of the dimeric UBA3-NAE1 E1 enzyme. E1 activates NEDD8 by first adenylating its C-terminal glycine residue with ATP, thereafter linking this residue to the side chain of the catalytic cysteine, yielding a NEDD8-UBA3 thioester and free AMP. E1 finally transfers NEDD8 to the catalytic cysteine of UBE2M. Necessary for cell cycle progression through the S-M checkpoint. Overexpression of NAE1 causes apoptosis through deregulation of NEDD8 conjugation. {ECO:0000269|PubMed:10207026, ECO:0000269|PubMed:10722740, ECO:0000269|PubMed:12740388}.;
- Pathway
- Alzheimer,s disease - Homo sapiens (human);Alzheimers Disease;Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.931
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.6
Haploinsufficiency Scores
- pHI
- 0.660
- hipred
- Y
- hipred_score
- 0.690
- ghis
- 0.674
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.854
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nae1
- Phenotype
- muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- signal transduction;protein modification by small protein conjugation;mitotic DNA replication checkpoint;regulation of apoptotic process;regulation of neuron apoptotic process;post-translational protein modification;protein neddylation;neuron apoptotic process
- Cellular component
- cytoplasm;cytosol;plasma membrane
- Molecular function
- protein binding;NEDD8 activating enzyme activity;ubiquitin protein ligase binding;protein heterodimerization activity